Abstract | BACKGROUND: Patients with locally advanced rectal cancer (LARC) have a dismal prognosis. We investigated outcomes and risk factors for locoregional recurrence (LRR) in patients treated with preoperative chemoradiotherapy (CRT), surgery and IOERT. METHODS: A total of 335 patients with LARC [⩾cT3 93% and/or cN+ 69%) were studied. In multivariate analyses, risk factors for LRR, IFLR and OFLR were assessed. RESULTS: Median follow-up was 72.6 months (range, 4-205). In multivariate analysis distal margin distance ⩽10 mm [HR 2.46, p = 0.03], R1 resection [HR 5.06, p = 0.02], tumor regression grade 1-2 [HR 2.63, p = 0.05] and tumor grade 3 [HR 7.79, p < 0.001] were associated with an increased risk of LRR. A risk model was generated to determine a prognostic index for individual patients with LARC. CONCLUSIONS: Overall results after multimodality treatment of LARC are promising. Classification of risk factors for LRR has contributed to propose a prognostic index that could allow us to guide risk-adapted tailored treatment.
|
Authors | Claudio V Sole, Felipe A Calvo, Javier Serrano, Emilio Del Valle, Marcos Rodriguez, Alberto Muñoz-Calero, Fernando Turégano, Jose Luis García-Sabrido, Pilar Garcia-Alfonso, Isabel Peligros, Sofia Rivera, Eric Deutsch, Emilio Alvarez |
Journal | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
(Radiother Oncol)
Vol. 112
Issue 1
Pg. 52-8
(Jul 2014)
ISSN: 1879-0887 [Electronic] Ireland |
PMID | 24997989
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Organoplatinum Compounds
- Tegafur
- Leucovorin
- Fluorouracil
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Chemoradiotherapy
(methods)
- Electrons
- Female
- Fluorouracil
(administration & dosage, therapeutic use)
- Humans
- Intraoperative Care
- Leucovorin
(therapeutic use)
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Recurrence, Local
(pathology)
- Organoplatinum Compounds
(therapeutic use)
- Prognosis
- Radiotherapy, Conformal
(methods)
- Rectal Neoplasms
(pathology, therapy)
- Tegafur
(administration & dosage)
|